MedTrace Logo

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

NCT06171139 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-04-16

No results posted yet for this study

Summary

The overall goal of the study is to improve equitable delivery of pre-Tumor genetic testing (TGT) counseling tool for Black or African American men with metastatic prostate cancer and evaluating the tool for implementation.

Conditions

Interventions

OTHER

Counseling Tool

Non-therapeutic educational intervention

OTHER

Questionnaires

Participants will complete questionnaires online, via mail, by telephone, or in person per participant preference.

Sponsors & Collaborators

Principal Investigators

  • Daniel Kwon, MD · University of California, San Francisco

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2027-05-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06171139 on ClinicalTrials.gov